Search - tctmd.com

Displaying 21 - 40 of 65

Sort: Relevancy | Date

Presentation NY Valves 2025

Timing for Intervention in Aortic Regurgitation

Presenter: Renuka Jain

June 26, 2025

Presentation NY Valves 2025

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Presenter: Jadon Ray Rajagopal

June 26, 2025

Presentation NY Valves 2025

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

Presenter: Ankit Gauba

June 25, 2025

Presentation NY Valves 2025

Rare Case of Acute Severe Mitral Regurgitation Following Transcatheter Aortic Valve Implantation (TAVI)

Presenter: Ho On Alston Conrad Chiu

June 25, 2025

Presentation NY Valves 2025

Successful Acute Valve-in-Valve Implantation Using Evolut FX Transcatheter Valve in a Failed Non-Calcified Stentless Subcoronary Toronto (SJM) Valve With Severe Aortic Regurgitation

Presenter: Virna Liza Sales

June 25, 2025

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Todd Neale

June 11, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Presenter: Torsten P. Vahl

June 07, 2024

Presentation NY Valves 2024

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

Presenter: Omar K. Khalique

June 07, 2024

Presentation NY Valves 2024

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

Presenter: Saif Anwaruddin

June 07, 2024

Presentation NY Valves 2024

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Presenter: Robert O. Bonow

June 07, 2024

Presentation NY Valves 2024

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Presenter: Sahar Samimi

June 07, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Advertisement

Timing for Intervention in Aortic Regurgitation

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

Rare Case of Acute Severe Mitral Regurgitation Following Transcatheter Aortic Valve Implantation (TAVI)

Successful Acute Valve-in-Valve Implantation Using Evolut FX Transcatheter Valve in a Failed Non-Calcified Stentless Subcoronary Toronto (SJM) Valve With Severe Aortic Regurgitation

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content